日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial

GMMG-CONCEPT试验中用于新诊断高危多发性骨髓瘤风险分层的心脏生物标志物

Leypoldt, Lisa B; Guo, Linlin; Besemer, Britta; Hänel, Mathias; Raab, Marc-S; Mann, Christoph; Michel, Christian S; Reinhardt, Hans Christian; Blau, Igor Wolfgang; Görner, Martin; Ko, Yon-Dschun; de Wit, Maike; Salwender, Hans; Scheid, Christof; Graeven, Ullrich; Peceny, Rudolf; Staib, Peter; Dieing, Annette; Goldschmidt, Hartmut; Bokemeyer, Carsten; Zeller, Tanja; Westermann, Dirk; Weisel, Katja C; Twerenbold, Raphael; Beitzen-Heineke, Antonia

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma

伊沙妥昔单抗、卡非佐米、来那度胺和地塞米松联合治疗高危新诊断多发性骨髓瘤

Leypoldt, Lisa B; Tichy, Diana; Besemer, Britta; Hänel, Mathias; Raab, Marc S; Mann, Christoph; Munder, Markus; Reinhardt, Hans Christian; Nogai, Axel; Görner, Martin; Ko, Yon-Dschun; de Wit, Maike; Salwender, Hans; Scheid, Christof; Graeven, Ullrich; Peceny, Rudolf; Staib, Peter; Dieing, Annette; Einsele, Hermann; Jauch, Anna; Hundemer, Michael; Zago, Manola; Požek, Ema; Benner, Axel; Bokemeyer, Carsten; Goldschmidt, Hartmut; Weisel, Katja C

Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma

伊沙妥昔单抗联合卡非佐米、来那度胺和地塞米松治疗高危新诊断多发性骨髓瘤患者的简明语言摘要

Leypoldt, Lisa B; Tichy, Diana; Besemer, Britta; Hanel, Mathias; Raab, Marc S; Mann, Christoph; Munder, Markus; Reinhardt, Hans Christian; Nogai, Axel; Gorner, Martin; Ko, Yon-Dschun; de Wit, Maike; Salwender, Hans; Scheid, Christof; Graeven, Ullrich; Peceny, Rudolf; Staib, Peter; Dieing, Annette; Einsele, Hermann; Jauch, Anna; Hundemer, Michael; Zago, Manola; Pozek, Ema; Benner, Axel; Bokemeyer, Carsten; Goldschmidt, Hartmut; Weisel, Katja C

A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy

一项针对不适合接受强化化疗的老年急性髓系白血病患者的随机II期临床试验,研究了尼达尼布联合低剂量阿糖胞苷的疗效。

Berdel, Andrew F; Koch, Raphael; Gerss, Joachim; Hentrich, Marcus; Peceny, Rudolf; Bartscht, Tobias; Steffen, Björn; Bischoff, Marina; Spiekermann, Karsten; Angenendt, Linus; Mikesch, Jan-Henrik; Kewitz, Tobias; Butterfass-Bahloul, Trude; Serve, Hubert; Lenz, Georg; Berdel, Wolfgang E; Krug, Utz; Schliemann, Christoph

Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial

经紫外线C波段处理、病原体灭活的血小板与未经处理的血小板的疗效比较:一项随机对照非劣效性试验

Brixner, Veronika; Bug, Gesine; Pohler, Petra; Krämer, Doris; Metzner, Bernd; Voss, Andreas; Casper, Jochen; Ritter, Ulrich; Klein, Stefan; Alakel, Nael; Peceny, Rudolf; Derigs, Hans G; Stegelmann, Frank; Wolf, Martin; Schrezenmeier, Hubert; Thiele, Thomas; Seifried, Erhard; Kapels, Hans-Hermann; Döscher, Andrea; Petershofen, Eduard K; Müller, Thomas H; Seltsam, Axel

Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers

德国三家癌症中心对合并SARS-CoV-2感染的癌症患者的诊断、临床及SARS-CoV-2感染后情况的回顾性分析

Shumilov, Evgenii; Hoffknecht, Petra; Koch, Raphael; Peceny, Rudolf; Voigt, Steffen; Schmidt, Nicole; Peeck, Micha; Bacher, Ulrike; Scheithauer, Simone; Trümper, Lorenz; Lenz, Georg; Kerkhoff, Andrea; Bleckmann, Annalen

Pbp2x localizes separately from Pbp2b and other peptidoglycan synthesis proteins during later stages of cell division of Streptococcus pneumoniae†D39.

在肺炎链球菌D39细胞分裂的后期阶段,Pbp2x与Pbp2b和其他肽聚糖合成蛋白的定位是分开的

Tsui Ho-Ching T, Boersma Michael J, Vella Stephen A, Kocaoglu Ozden, Kuru Erkin, Peceny Julia K, Carlson Erin E, VanNieuwenhze Michael S, Brun Yves V, Shaw Sidney L, Winkler Malcolm E

Erythropoietin increases reticulocyte counts and maintains hematocrit in neonates requiring surgery

促红细胞生成素可增加网织红细胞计数并维持需要手术的新生儿的血细胞比容。

Bierer, Ryann; Roohi, Mahshid; Peceny, Connie; Ohls, Robin K